These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10936320)

  • 1. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation.
    Yin DP; Sankary HN; Shen J; Ma LL; Blinder L; Foster P; Williams JW; Chong A
    Transplant Proc; 2000 Aug; 32(5):1003-4. PubMed ID: 10936320
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of tacrolimus (FK506) in hamster-to-rat pancreas xenotransplantation.
    Sakimoto H; Fukuda Y; Sumimoto K; Urushihara T; Ikeda M; Yamanaka K; Okugawa K; Nishihara M; Ito H; Dohi K
    Transplant Proc; 1996 Jun; 28(3):1433-4. PubMed ID: 8658727
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig.
    Yin DP; Sankary HN; Williams J; Krieger N; Fathman CG
    Transplantation; 1996 Dec; 62(11):1537-9. PubMed ID: 8970603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats.
    Yin DP; Sankary HN; Chong AS; Blinder L; Ma LL; Williams JW
    Transplantation; 1997 Jul; 64(2):317-21. PubMed ID: 9256194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival of hamster-to-rat pancreas xenografts by FK 506 and splenectomy.
    Sakimoto H; Fukuda Y; Sumimoto K; Urushihara T; Ikeda M; Yamanaka K; Okugawa K; Nishihara M; Ito H; Dohi K
    Transplant Proc; 1995 Feb; 27(1):296-7. PubMed ID: 7533394
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
    Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts.
    Onodera K; Chandraker A; Korom S; Stadlbauer TH; Kato K; Kasai S; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1998 Feb; 30(1):16-8. PubMed ID: 9474943
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
    Tu Y; Rehman A; Flye MW
    Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
    [No Abstract]   [Full Text] [Related]  

  • 10. CTLA4Ig Inhibits humoral and cellular immune responses to concordant xenografts.
    Ibrahim S; Xu R; Burdick JF; Baldwin W; Sanfilippo F; Kittur DS
    Transplant Proc; 1996 Apr; 28(2):715-6. PubMed ID: 8623361
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig.
    Feng S; Quickel RR; Hollister-Lock J; McLeod M; Bonner-Weir S; Mulligan RC; Weir GC
    Transplantation; 1999 Jun; 67(12):1607-13. PubMed ID: 10401769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
    Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft.
    Miao G; Ito T; Uchikoshi F; Akamaru Y; Kiyomoto T; Komodo H; Song J; Nozawa M; Matsuda H
    Transplantation; 2004 Jul; 78(1):59-64. PubMed ID: 15257039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J; Marath A; Rayat G; Thliveris J; Koshal A; Yatscoff R
    Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
    Zhang L; Qi Z; Wu D; Shan S; Ekberg H
    Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4Ig inhibits alloantibody responses to transfusions and transplants.
    Ibrahim S; Jakobs F; Linsley PS; Sanfilippo F; Baldwin WM
    Transplant Proc; 1997; 29(1-2):1025. PubMed ID: 9123179
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
    Onodera K; Chandraker A; Kato H; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1999; 31(1-2):876-7. PubMed ID: 10083384
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.